BRIEF published on 03/16/2026 at 17:52, 3 months 9 days ago HBM Healthcare Investments AG publie les chiffres clés de mars Performance Financière Valeur Nette D'actif Analyse Des Investissements Prix De L'action HBM Healthcare
PRESS RELEASE published on 03/16/2026 at 17:47, 3 months 9 days ago Key Figures 15.03.2026 HBM Healthcare Investments AG releases key performance figures for March 15, 2026, showing fluctuations in NAV and share price Performance HBM Healthcare Investments AG Key Figures Share Price NAV
BRIEF published on 03/02/2026 at 17:52, 3 months 23 days ago HBM Healthcare Investments AG publie ses résultats mensuels Rapport Financier NAV Prix De L'action HBM Healthcare Indicateurs De Performance
BRIEF published on 03/02/2026 at 17:52, 3 months 23 days ago HBM Healthcare Investments AG Reports Monthly Performance Figures Financial Report Share Price NAV HBM Healthcare Performance Metrics
PRESS RELEASE published on 03/02/2026 at 17:47, 3 months 23 days ago Key Figures 28.02.2026 HBM Healthcare Investments AG reports key figures for February 2026, with NAV at 275.58 CHF and Share Price at 222.00 CHF. Performance percentages shown HBM Healthcare Investments AG Key Figures Share Price NAV February 2026
BRIEF published on 02/16/2026 at 17:51, 4 months 9 days ago HBM Healthcare Reports February 2026 Financial Performance Financial Figures Share Price NAV HBM Healthcare February 2026
BRIEF published on 02/16/2026 at 17:51, 4 months 9 days ago HBM Healthcare publie ses résultats financiers de février 2026 NAV Données Financières Prix De L'action HBM Healthcare Février 2026
PRESS RELEASE published on 02/16/2026 at 17:46, 4 months 9 days ago Key Figures 15.02.2026 HBM Healthcare Investments AG reported key figures for 15.02.2026, showing performance in CHF. NAV at 272.51, Share Price at 220.00, and Total Net Assets at 1'806 million Performance HBM Healthcare Investments AG Key Figures CHF 15.02.2026
BRIEF published on 02/02/2026 at 17:51, 4 months 23 days ago HBM Healthcare Investments AG publie ses principaux chiffres pour janvier 2026 Performance Financière Valeur Nette D'actif Prix De L'action HBM Healthcare Risque D'investissement
BRIEF published on 02/02/2026 at 17:51, 4 months 23 days ago HBM Healthcare Investments AG Releases Key Figures for January 2026 Financial Performance Net Asset Value Share Price HBM Healthcare Investment Risk
Published on 06/26/2026 at 01:40, 10 hours 11 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 12 hours 21 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 13 hours 21 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 14 hours 19 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 20 hours 21 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 11:14, 36 minutes ago EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Published on 06/26/2026 at 11:05, 45 minutes ago Join the Beautiful Game: Discover Immersive Fan Experiences with Hisense at FIFA World Cup 2026™
Published on 06/26/2026 at 10:59, 51 minutes ago HELIOS SOLAR AG starts subscription period for Initial Public Offering – shares offered at EUR 4.00
Published on 06/26/2026 at 10:50, 1 hour ago Indotek Group acquires remaining 53% stake in Auchan Hungary, assumes full ownership
Published on 06/26/2026 at 07:00, 4 hours 51 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 4 hours 51 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 17 hours 5 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 17 hours 21 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 18 hours 1 minute ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
